Priyatam Khadka1, Januka Thapaliya2, Shovana Thapa3. 1. Medical Microbiology, Tri-Chandra Multiple Campus, Kathmandu, Nepal. khadka.priyatam@gmail.com. 2. Medical Microbiology, Tri-Chandra Multiple Campus, Kathmandu, Nepal. 3. International Friendship Children's Hospital, Kathmandu, Nepal.
Abstract
BACKGROUND: In most low-income countries, febrile-pediatric-cases are often treated empirically with accessible antibiotics without periodic epidemiological surveillance, susceptibility testing, or minimal lethal dose calculations. With this backdrop, the study was undertaken to evaluate the susceptibility trend of Salmonella enterica against the commonly prescribed antibiotics. METHODS: All isolates of Salmonella enterica were identified by standard protocols of biotyping and serotyping, then tested against antibiotics by the modified Kirby disk-diffusion method. Minimum Inhibitory Concentration (MIC) of isolates was determined by the agar-dilution method and compared with disk diffusion results and on nalidixic-acid sensitive/resistant strains. RESULTS: Among 1815 febrile-pediatric patients, 90(4.9%) isolates of Salmonella enterica [serovar: Salmonella Typhi 62(68.8%) and Salmonella Paratyphi A 28(31.1%)] were recovered. The incidence of infection was higher among males, age groups 5 to 9, and patients enrolling in the out-patient department (OPD). On the disk-diffusion test, most isolates were sensitive against first-line drugs i.e.cephalosporins, and macrolides. However, against quinolones, a huge percentile 93.3%, of isolates were resistant [including 58 Typhiand 26 Paratyphiserovar] while nearly 14% were resistant against fluoroquinolones. When MICs breakpoint were adjusted as follows: 4 μg/ml for azithromycin, ≥1 μg/ml for ciprofloxacin, 2 μg/ml for ofloxacin, 8 μg/ml for nalidixic acid, and 1 μg/ml for cefixime, higher sensitivity and specificity achieved. Compared to other tested antibiotics, a low rate of azithromycin resistance was observed. Nevertheless, higher resistance against fluoroquinolones was observed on NARS strain. CONCLUSION: Higher susceptibility of Salmonella enterica to the conventional anti-typhoidal drugs (amoxicillin, chloramphenicol, cotrimoxazole, cephotaxime) advocates for its reconsideration. Although, the lower susceptibility against fluoroquinolones among nalidixic-acid-resistant Salmonella (NARS) strain negates its empirical use among the study age group.
BACKGROUND: In most low-income countries, febrile-pediatric-cases are often treated empirically with accessible antibiotics without periodic epidemiological surveillance, susceptibility testing, or minimal lethal dose calculations. With this backdrop, the study was undertaken to evaluate the susceptibility trend of Salmonella enterica against the commonly prescribed antibiotics. METHODS: All isolates of Salmonella enterica were identified by standard protocols of biotyping and serotyping, then tested against antibiotics by the modified Kirby disk-diffusion method. Minimum Inhibitory Concentration (MIC) of isolates was determined by the agar-dilution method and compared with disk diffusion results and on nalidixic-acid sensitive/resistant strains. RESULTS: Among 1815 febrile-pediatric patients, 90(4.9%) isolates of Salmonella enterica [serovar: Salmonella Typhi 62(68.8%) and Salmonella Paratyphi A 28(31.1%)] were recovered. The incidence of infection was higher among males, age groups 5 to 9, and patients enrolling in the out-patient department (OPD). On the disk-diffusion test, most isolates were sensitive against first-line drugs i.e.cephalosporins, and macrolides. However, against quinolones, a huge percentile 93.3%, of isolates were resistant [including 58 Typhiand 26 Paratyphiserovar] while nearly 14% were resistant against fluoroquinolones. When MICs breakpoint were adjusted as follows: 4 μg/ml for azithromycin, ≥1 μg/ml for ciprofloxacin, 2 μg/ml for ofloxacin, 8 μg/ml for nalidixic acid, and 1 μg/ml for cefixime, higher sensitivity and specificity achieved. Compared to other tested antibiotics, a low rate of azithromycin resistance was observed. Nevertheless, higher resistance against fluoroquinolones was observed on NARS strain. CONCLUSION: Higher susceptibility of Salmonella enterica to the conventional anti-typhoidal drugs (amoxicillin, chloramphenicol, cotrimoxazole, cephotaxime) advocates for its reconsideration. Although, the lower susceptibility against fluoroquinolones among nalidixic-acid-resistant Salmonella (NARS) strain negates its empirical use among the study age group.
Authors: Tran Thuy Chau; James Ian Campbell; Claudia M Galindo; Nguyen Van Minh Hoang; To Song Diep; Tran Thu Thi Nga; Nguyen Van Vinh Chau; Phung Quoc Tuan; Anne Laure Page; R Leon Ochiai; Constance Schultsz; John Wain; Zulfiqar A Bhutta; Christopher M Parry; Sujit K Bhattacharya; Shanta Dutta; Magdarina Agtini; Baiqing Dong; Yang Honghui; Dang Duc Anh; Do Gia Canh; Aliya Naheed; M John Albert; Rattanaphone Phetsouvanh; Paul N Newton; Buddha Basnyat; Amit Arjyal; Tran Thi Phi La; Nguyen Ngoc Rang; Le Thi Phuong; Phan Van Be Bay; Lorenz von Seidlein; Gordon Dougan; John D Clemens; Ha Vinh; Tran Tinh Hien; Nguyen Tran Chinh; Camilo J Acosta; Jeremy Farrar; Christiane Dolecek Journal: Antimicrob Agents Chemother Date: 2007-10-01 Impact factor: 5.191
Authors: Vanessa K Wong; Stephen Baker; Derek J Pickard; Julian Parkhill; Andrew J Page; Nicholas A Feasey; Robert A Kingsley; Nicholas R Thomson; Jacqueline A Keane; François-Xavier Weill; David J Edwards; Jane Hawkey; Simon R Harris; Alison E Mather; Amy K Cain; James Hadfield; Peter J Hart; Nga Tran Vu Thieu; Elizabeth J Klemm; Dafni A Glinos; Robert F Breiman; Conall H Watson; Samuel Kariuki; Melita A Gordon; Robert S Heyderman; Chinyere Okoro; Jan Jacobs; Octavie Lunguya; W John Edmunds; Chisomo Msefula; Jose A Chabalgoity; Mike Kama; Kylie Jenkins; Shanta Dutta; Florian Marks; Josefina Campos; Corinne Thompson; Stephen Obaro; Calman A MacLennan; Christiane Dolecek; Karen H Keddy; Anthony M Smith; Christopher M Parry; Abhilasha Karkey; E Kim Mulholland; James I Campbell; Sabina Dongol; Buddha Basnyat; Muriel Dufour; Don Bandaranayake; Take Toleafoa Naseri; Shalini Pravin Singh; Mochammad Hatta; Paul Newton; Robert S Onsare; Lupeoletalalei Isaia; David Dance; Viengmon Davong; Guy Thwaites; Lalith Wijedoru; John A Crump; Elizabeth De Pinna; Satheesh Nair; Eric J Nilles; Duy Pham Thanh; Paul Turner; Sona Soeng; Mary Valcanis; Joan Powling; Karolina Dimovski; Geoff Hogg; Jeremy Farrar; Kathryn E Holt; Gordon Dougan Journal: Nat Genet Date: 2015-05-11 Impact factor: 38.330
Authors: Rahul Pradhan; Umesh Shrestha; Samir C Gautam; Stephen Thorson; Kabindra Shrestha; Bharat K Yadav; Dominic F Kelly; Neelam Adhikari; Andrew J Pollard; David R Murdoch Journal: PLoS One Date: 2012-10-24 Impact factor: 3.240